John M. Pagel, MD, PhD

John M. Pagel, MD, PhD, is chief of hematologic malignancies and the director of stem cell transplantation at the Swedish Cancer Institute in Seattle, WA. 

His research interests include the development and discovery of novel therapeutics for the treatment of blood cancers, such as lymphoma and leukemia. His current research focuses on strategies for delivering innovative targeted immunotherapy agents to patients with hematologic malignancies. Dr Pagel’s research has resulted in more than 100 publications in peer-reviewed journals, including, but not limited to, The New England Journal of Medicine, Blood, the Journal of Clinical Oncology, and Bone Marrow Transplantation, as well as numerous abstracts of papers at national and international meetings.